[1] Dodi I,Raggi V,Verna M,et al.Atipical Kawasaki disease with coronary aneurysm in infant[J].Ital J Pediatr,2011,37(4):19. [2] 时艳艳,刘芳,吴琳,等.川崎病冠状动脉病变严重程度临床分级及高危因素研究[J].中国实用儿科杂志,2014,29(9):681-686. [3] Gerding R.Kawasaki disease:a review[J].J Pediatr Health Care,2011,25(6):379-387. [4] Liu AM,Ghazizadeh M,Onouchi Z,et al.Ultrastructural characteristics of myocardial and coronary microvascular lesions in Kawasaki disease[J].Microvasc Res,1999,58(1):10-27. [5] Dou J,Li H,Sun L,et al.Histopathological and ultrastructural examinations of rabbit coronary artery vasculitis caused by bovine serum albumin:an animal model of Kawasaki disease[J].Ultrastruct Pathol,2013,37(2):139-145. [6] Pietraforte D,Gambardella L,Marchesi A,et al.Platelets in Kawasaki patients:two different populations with different mitochondrial functions[J].Int J Cardiol,2014,172(2):526-528. [7] Duong TT,Silverman ED,Bissessar MV,et al.Superantigenic activity is responsible for induction of coronary arteritis in mice:an animal model of Kawasaki disease[J].Int Immunol,2003,15(1):79-89. [8] Arruda AP,Pers BM,Parlakgul G,et al.Chronic enrichment of hepatic endoplasmic reticulum-mitochondria contact leads to mitochondrial dysfunction in obesity[J].Nat Med,2014,20(12):1427-1435. [9] Yoshikane Y,Koga M,Imanaka-Yoshida K,et al.JNK is critical for the development of Candida albicans-induced vascular lesions in a mouse model of Kawasaki disease[J].Cardiovasc Pathol,2015,24(1):33-40. [10] 斯徐伟,奚赛飞,徐孝平,等.ZDF与SD大鼠动脉粥样硬化形成及其磷脂酶A2表达的比较研究[J].实验动物与比较医学,2015,35(1):10-16. [11] Manlhiot C,Mueller B,O’Shea S,et al.Environmental epidemiology of Kawasaki disease:Linking disease etiology,pathogenesis and global distribution[J].PLoS One,2018,13(2):e191087. [12] Orenstein JM,Shulman ST,Fox LM,et al.Three linked vasculopathic processes characterize Kawasaki disease:a light and transmission electron microscopic study[J].PLoS One,2012,7(6):e38998. [13] Ishibashi K,Fukazawa R,Miura NN,et al.Diagnostic potential of antibody titres against Candida cell wall beta-glucan in Kawasaki disease[J].Clin Exp Immunol,2014,177(1):161-167. [14] Gero D,Torregrossa R,Perry A,et al.The novel mitochondria-targeted hydrogen sulfide (H2S) donors AP123 and AP39 protect against hyperglycemic injury in microvascular endothelial cells in vitro[J].Pharmacol Res,2016,113(Pt A):186-198. [15] Kirsch J,Schneider H,Pagel JI,et al.Endothelial dysfunction,and a prothrombotic,proinflammatory phenotype is caused by loss of mitochondrial thioredoxin reductase in endothelium[J].Arterioscler Thromb Vasc Biol,2016,36(9):1891-1899. [16] Hamaoka-Okamoto A,Suzuki C,Yahata T,et al.The involvement of the vasa vasorum in the development of vasculitis in animal model of Kawasaki disease[J].Pediatr Rheumatol Online J,2014,12(3):12. [17] Yan ZT,Zou JW.Triptolide as an alternative to IVIG therapy for Kawasaki disease in a mouse model[J].Balkan Med J,2013,30(2):225-228. |